BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24451006)

  • 1. Predicting progression to lymphoma in Sjögren's syndrome patients.
    Giannouli S; Voulgarelis M
    Expert Rev Clin Immunol; 2014 Apr; 10(4):501-12. PubMed ID: 24451006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosis.
    Voulgarelis M; Moutsopoulos HM
    Rheum Dis Clin North Am; 2008 Nov; 34(4):921-33, viii. PubMed ID: 18984412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of the patients with primary Sjögren's syndrome complicated with lymphoma].
    Li YQ; Yu QM; Li J; Yang JR; Niu T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):467-9. PubMed ID: 22812260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical prediction rule for lymphoma development in primary Sjögren's syndrome.
    Baldini C; Pepe P; Luciano N; Ferro F; Talarico R; Grossi S; Tavoni A; Bombardieri S
    J Rheumatol; 2012 Apr; 39(4):804-8. PubMed ID: 22337248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
    Risselada AP; Kruize AA; Bijlsma JW
    Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
    Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M
    Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant lymphoma in primary Sjögren's syndrome: an update on the pathogenesis and treatment.
    Routsias JG; Goules JD; Charalampakis G; Tzima S; Papageorgiou A; Voulgarelis M
    Semin Arthritis Rheum; 2013 Oct; 43(2):178-86. PubMed ID: 23816048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of patients with primary Sjögren's syndrome and non-Hodgkin's lymphoma: analysis of 9 cases].
    Jia N; Tang FL
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(39):2786-8. PubMed ID: 20137605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
    Smedby KE; Baecklund E; Askling J
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and prognostic characteristics of 573 cases of primary Sjögren's syndrome.
    Lin DF; Yan SM; Zhao Y; Zhang W; Li MT; Zeng XF; Zhang FC; Dong Y
    Chin Med J (Engl); 2010 Nov; 123(22):3252-7. PubMed ID: 21163125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces?
    Baecklund E; Smedby KE; Sutton LA; Askling J; Rosenquist R
    Semin Cancer Biol; 2014 Feb; 24():61-70. PubMed ID: 24333759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
    Tzioufas AG; Voulgarelis M
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):989-1010. PubMed ID: 18068857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren's syndrome.
    Risselada AP; Kruize AA; Goldschmeding R; Lafeber FP; Bijlsma JW; van Roon JA
    Ann Rheum Dis; 2014 Aug; 73(8):1537-40. PubMed ID: 24525912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
    Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
    Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of parotid gland biopsy in early detection of lymphoma in primary Sjogren's syndrome].
    Vasil'iev VI; Logvinenko OA; Probatova NA; Kokosadze NV; Gorodetskiĭ VR; Kovrigina AM; Kondrat'eva TT; Mitrikov BV; Gaĭduk IV; Safonova TN; Simonova MV; Radenska-Lopovok SG; Varlamova EIu
    Ter Arkh; 2009; 81(6):20-7. PubMed ID: 19663187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do we know about memory B cells in primary Sjögren's syndrome?
    Hansen A; Daridon C; Dörner T
    Autoimmun Rev; 2010 Jul; 9(9):600-3. PubMed ID: 20452465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Sjögren's syndrome and its lymphoid malignancy: a report of four cases.
    Dong Y; Zhao Y; Zeng X; Sun D
    Chin Med J (Engl); 1998 Mar; 111(3):218-9. PubMed ID: 10374419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical picture, outcome and predictive factors of lymphoma in Sjӧgren syndrome.
    Papageorgiou A; Voulgarelis M; Tzioufas AG
    Autoimmun Rev; 2015 Jul; 14(7):641-9. PubMed ID: 25808075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pseudo-lymphomas of the ocular adnexa: their relations to Sjögren's syndrome (author's transl)].
    Dhermy P; Diebold J; Audoin J; Tricot G
    J Fr Ophtalmol; 1981; 4(12):787-96. PubMed ID: 7035538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study.
    Pollard RP; Pijpe J; Bootsma H; Spijkervet FK; Kluin PM; Roodenburg JL; Kallenberg CG; Vissink A; van Imhoff GW
    J Rheumatol; 2011 Oct; 38(10):2198-208. PubMed ID: 21844152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.